ERYFOTONA AK-NMSC FLUID

Organization name

ISDIN, S.A

SRN

ES-MF-000003221

Manufacturer status

Active

1 warning recorded — scroll inside the panel to see all entries.

• CW999

  Warnings: use only on clean, intact skin. Daily continuous use is necessary to prevent and treat AK and NMSC coadjuvantly. For patients undergoing pharmacological or surgical treatment for AK or NMSC, treatment with Eryfotona should be started once the lesions are closed. Precautions: shake before use. Read leaflet carefully before use. Avoid contact with eyes and mucous membranes. In case of an adverse reaction to any of the ingredients, stop treatment and consult your physician. Keep out of reach and sight of children. No special conservation conditions are required.

Primary placement in Spain; available across 16 countries total.

Trade name

ERYFOTONA AK-NMSC FLUID

UDI-DI code

D-ES-MF-0000032212G

Basic UDI-DI

B-ES-MF-0000032212G

Reference / catalog number

4710090

Issuing entity

EUDAMED

Risk category

Class IIa

Applicable legislation

MDD [Directive 93/42/EEC on medical devices]

Status

On the market

Quantity

1

Additional product description

—

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

No clinical sizes registered for this device.

• V9099VARIOUS DEVICES NOT INCLUDED IN OTHER CLASSES - OTHER

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification